rHuEPO dose inversely correlated with the number of circulating CD34+ cells in maintenance hemodialysis patients

Nephron - Clinical Practice

Volumn 108, Issue 1, 2008, Pages

  Kohagura, Kentaro ^a   Ohya, Yusuke ^a   Miyagi, Shinyu ^b   Ishida, Akio ^a   Yakabi, Shizuko ^a   Iseki, Kunitoshi ^a   Yamane, Nobuhisa ^a   Takishita, Shuichi ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b Okinawa Dai ichi Hospital   (Japan)

Author keywords

Anemia; Circulating CD34+ cells; Endothelial progenitor cells; Maintenance hemodialysis patients; Recombinant human erythropoietin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FERRITIN; RECOMBINANT ERYTHROPOIETIN; STATIN;

ADULT; AGED; ANEMIA; ARTICLE; CD34 SELECTION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; ERYTHROID PRECURSOR CELL; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL;

AGED; ANTIGENS, CD34; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 39149137231     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112528     Document Type: Article

References (29)

1. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
2. Tozawa M, Iseki K, Iseki C, Oshiro S, Yamazato M, Higashiuesato Y, Tomiyama N, Tana T, Ikemiya Y, Takishita S: Evidence for elevated pulse pressure in patients on chronic hemodialysis: a case-control study. Kidney Int 2002;62:2195-2201.
3. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999;10:610-619.
4. Zoccali C, Mallamaci F, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004;15(suppl 1):S77-S80.
5. Eizawa T, Murakami Y, Matsui K, Takahashi M, Muroi K, Amemiya M, Takano R, Kusano E, Shimada K, Ikeda U: Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003;19:627-633.
6. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
7. Nakao K, Wada J, Ota K, Ichikawa H, Akagi S, Okamoto A, Hida K, Nagake Y, Makino H: Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients. Am J Kidney Dis 2003;41:624-636.
8. Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ: Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 2004;44:866-876.
9. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006;17:1181-1191.
10. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D: Erythropoietin regulates endothelial progenitor cells. Blood 2004;103:921-926.
11. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102:1340-1346.
12. Bahlmann FH, de Groot K, Haller H, Fliser D: Erythropoietin: is it more than correcting anaemia? Nephrol Dial Transplant 2004;19:20-22.
13. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB: Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991;77:2591-2596.
14. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H: Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004;109:2972-2975.
15. Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M: 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial 2004;8:443-459.
16. Takeda A, Toda T, Shinohara S, Mogi Y, Matsui N: Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. Am J Kidney Dis 2002;40:104-109.
17. Drueke T: Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001;16(suppl 7):25-28.
18. Stenvinkel P: The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001;16(suppl 7):36-40.
19. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD: Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003;42:761-773.
20. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ: Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97:3075-3085.
21. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A: Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45:1449-1457.
22. Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Cardiac disease in diabetic end-stage renal disease. Diabetologia 1997;40:1307-1312.
23. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-2890.
24. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
25. Ozawa T, Toba K, Kato K, Minagawa S, Saigawa T, Hanawa H, Makiyama Y, Moriyama M, Honma K, Isoda M, Hasegawa G, Naito M, Takahashi M, Aizawa Y: Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J Mol Cell Cardiol 2006;40:629-638.
26. Sasaki S, Inoguchi T, Muta K, Abe Y, Zhang M, Hiasa K, Egashira K, Sonoda N, Kobayashi K, Takayanagi R, Nawata H: Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells. Am J Physiol 2007;292:H657-H665.
27. Perey L, Peters R, Pampallona S, Schneider P, Gross N, Leyvraz S: Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors. Br J Haematol 1998;103:618-629.
28. Rehman J, Li J, Orschell CM, March KL: Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-1169.
29. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, Shimada K, Ogawa H, Daida H, Hattori K, Ohsaka A: Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005;19:2005-2007.